We are live on ! Find out more
MRCM

M&R Capital Management Portfolio holdings

AUM $454M
1-Year Est. Return 40.11%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$419M
AUM Growth
+$10.9M
Cap. Flow
+$2.31M
Cap. Flow %
0.55%
Top 10 Hldgs %
47.82%
Holding
559
New
11
Increased
126
Reduced
102
Closed
12

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$8.37M
2
CACI icon
CACI
CACI
+$5.74M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$2.32M
4
PEP icon
PepsiCo
PEP
+$1.38M
5
ACGL icon
Arch Capital
ACGL
+$1.25M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$8.98M
2
CMCSA icon
Comcast
CMCSA
+$2.47M
3
LW icon
Lamb Weston
LW
+$2.32M
4
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$1.3M
5
MMM icon
3M
MMM
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 27.36%
2 Financials 20.03%
3 Healthcare 10.65%
4 Communication Services 9.1%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.67T
$35.4M 8.44%
167,951
-1,926
-1% -$359K
AVGO icon
2
Broadcom
AVGO
$1.75T
$31.3M 7.47%
194,930
-5,130
-3% -$719K
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.08T
$25.7M 6.13%
63,214
-169
-0.3% -$69.1K
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.24T
$23.3M 5.55%
127,761
-995
-0.8% -$168K
LOW icon
5
Lowe's Companies
LOW
$117B
$15.6M 3.71%
70,626
-291
-0.4% -$66.4K
MRK icon
6
Merck
MRK
$366B
$15.5M 3.69%
124,879
+1,227
+1% +$158K
AMZN icon
7
Amazon
AMZN
$2.87T
$15.4M 3.66%
79,470
+142
+0.2% +$26.1K
V icon
8
Visa
V
$712B
$14.1M 3.37%
53,748
-7
-0% -$1.92K
MSFT icon
9
Microsoft
MSFT
$3.81T
$12.9M 3.08%
28,919
-46
-0.2% -$19.4K
JPM icon
10
JPMorgan Chase
JPM
$951B
$11.4M 2.72%
56,299
+230
+0.4% +$45K
GOOG icon
11
Alphabet (Google) Class C
GOOG
$4.19T
$10.1M 2.41%
54,971
-40
-0.1% -$6.8K
AZN icon
12
AstraZeneca
AZN
$252B
$8.75M 2.09%
56,077
+55,632
+12,502% +$8.37M
DVN icon
13
Devon Energy
DVN
$52.1B
$8.33M 1.99%
175,661
+986
+0.6% +$49K
FISV
14
Fiserv Inc
FISV
$28.3B
$8.09M 1.93%
54,248
-80
-0.1% -$12.1K
PEP icon
15
PepsiCo
PEP
$193B
$7.94M 1.89%
48,131
+7,981
+20% +$1.38M
CACI icon
16
CACI
CACI
$13.9B
$7.28M 1.74%
16,930
+14,047
+487% +$5.74M
NVDA icon
17
NVIDIA
NVDA
$5.25T
$7M 1.67%
56,668
+488
+0.9% +$49.3K
CFG icon
18
Citizens Financial Group
CFG
$29.4B
$6.58M 1.57%
182,623
-4,853
-3% -$169K
JPST icon
19
JPMorgan Ultra-Short Income ETF
JPST
$40.8B
$6.04M 1.44%
119,627
-25,784
-18% -$1.3M
COST icon
20
Costco
COST
$419B
$5.59M 1.33%
6,573
-2
-0% -$1.56K
MMM icon
21
3M
MMM
$89.9B
$5.46M 1.3%
53,416
-10,705
-17% -$1.04M
C icon
22
Citigroup
C
$223B
$5.32M 1.27%
83,911
+2,180
+3% +$134K
FDX icon
23
FedEx
FDX
$78.3B
$4.91M 1.17%
16,360
+2
+0% +$523
ACN icon
24
Accenture
ACN
$116B
$4.52M 1.08%
14,910
-8
-0.1% -$2.45K
NSC icon
25
Norfolk Southern
NSC
$78.3B
$4.19M 1%
19,499
+1
+0% +$232

Similar funds

M&R Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, M&R Capital Management held 559 positions worth $419M, up 2.7% from $408M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 4.1%. M&R Capital Management opened 11 new positions and exited 12, leaving the 559-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • M&R Capital Management's largest Q2 2024 buy was KeyCorp: 11,973 shares worth $170K.
  • M&R Capital Management added most to AstraZeneca in Q2 2024, an estimated $8.37M increase.
  • M&R Capital Management's biggest Q2 2024 reduction was CVS Health, cutting an estimated $8.98M.
  • M&R Capital Management fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $42.7K.
  • M&R Capital Management's ten largest holdings make up 48% of its $419M portfolio in Q2 2024.
  • M&R Capital Management opened 11 new positions and closed 12 in Q2 2024.
  • M&R Capital Management's portfolio value rose 2.7% quarter-over-quarter to $419M.

Based on M&R Capital Management's 13F filing for Q2 2024, filed 2 Jul 2024.